Department Affiliation
Assistant Professor
Interests
Hematopathology
Molecular genetic pathology
Education and Training
Fellowship, Molecular Genetics, MD Anderson Cancer Center, Houston, TX, 2020
Fellowship, Hematopathology, MD Anderson Cancer Center, Houston, TX 2019
Residency, Lenox Hill Hospital, New York City, NY, 2017
Internal Medicine Internship, Fletcher Allen Health Care, University of Vermont Medical Center, Burlington, VT, 2011
MD, Boston University School of Medicine, Boston, Massachusetts, 2009
PhD, Immunology, University of Utrecht Medical Center, Utrecht, The Netherlands, 2007
National Activities
College of American Pathologists, 2013 – present
American Society of Clinical Pathology
Medical Society of the State of New York
Harris County Medical Society
Texas Medical Association
Notable publications
Ronaghy A, Hu S, Tang Z, Wang W, Lin P, Tang G, Loghavi S, Li L, Thakral B, Medeiros LJ, Muzzafar T. Myeloid Neoplasms Associated with t(3;12)(q26.2;p13) Are Clinically Aggressive, Show Myelodysplasia, and Frequently Harbor Chromosome 7 Abnormalities. Mod. Pathol. 2021 Feb;34(2):300-313.
Ronaghy A, Yang RK, Khoury JD, Kanagal-Shamanna, R. Clinical Applications of Array Comparative Genomic Hybridization in Myeloid Neoplasms. Curr Hematol Malig Rep. 2020 Jun;15(3):194-202.
Ronaghy A, Xiao GQ, Santagada E, Hasanovic A, Unger P. Expression of GATA-3 in Testicular and Gynecologic Mesothelial Neoplastic and Non-neoplastic Tissues. Int J Gynecol Pathol. 2017 Jun 2.
Ronaghy A, Wang HY, Thorson JA, et al. PD-L1 and Notch1 Expression in KSHV/HHV-8- and EBV Associated Germinotropic Lymphoproliferative Disorder: Case Report and Review of the Literature. Pathology. 2017 Jun;49(4):430-435.
Ronaghy A, Streilein RD, Hall RP 3rd. Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP). J Dermatol Sci. 2014 Apr;74(1):934. Padler-Karavani V, Hurtado-Ziola N, Chang YC, Sonnenburg JL, Ronaghy A, et al. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates. FASEB J. 2014 Mar;28(3):1280-93.
Hall RP 3rd, Streilein RD, Hannah DL, McNair PD, Fairley JA, Ronaghy A, et al. Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients. J Invest Dermatol. 2013 Dec;133(12):2786-8.
Ronaghy A, de Jager W, Zonneveld-Huijssoon E, et al. Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis.
Ronaghy A, Yaar R, Goldberg LJ, Mahalingam M, Bhawan J. Perineural involvement: what does it mean? Am J Dermatopathol. 2010 Jul;32(5):469-76.
Zonneveld-Huijssoon E, Ronaghy A, Van Rossum MA, et al. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. Arthritis Rheum. 2007 Feb;56(2):639-46. 11. Roord ST, Zonneveld-Huijssoon E, Le T, Yung GP, Koffeman E, Ronaghy A, et al. Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis. PLoS One. 2006 Dec 20;1:e87.
Ronaghy A, Prakken BJ, Takabayashi K, Firestein GS, Boyle D, Zvailfler NJ, Roord STA, Albani S, Carson DA, Raz E. Immunostimulatory DNA sequences influce the course of adjuvant arthritis. J Immunol. 2002 Jan 1;168(1):51-6. doi: 10.4049/jimmunol.168.1.51.
Roman M, Martin-Orozcon E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med. 1997 Aug;3(8):849-54. dio: 10.1038/nm0897-849.
For a detailed list of publications.